| Jul 2 |
(GOVX) - Analyzing Geovax Labs's Short Interest
|
| Jun 27 |
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
|
| Jun 18 |
GeoVax stock rockets 50% on BARDA award for COVID-19 vaccine
|
| Jun 18 |
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
|
| Jun 7 |
GeoVax files to sell 1.61M shares of common stock for holders
|
| May 29 |
GeoVax to Present at BIO International Convention 2024
|
